Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Unknown 2Terminated 2Recruiting 2Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2Head & Neck 1Gastrointestinal 1

Conditions

Melanoma 4Neuroblastoma 3Uterine Cervical Neoplasms 2Nasopharyngeal Carcinoma 2Lymphoma, Non-Hodgkin 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Hepatocellular 2Breast Neoplasms 2Stomach Neoplasms 1Solid Tumors 1Solid Tumor 1Recurrence 1Ovarian Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Lymphoma, T-Cell 1Lymphoma, Large B-Cell, Diffuse 1Lung Neoplasms 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hodgkin Disease 1Head and Neck Neoplasms 1Carcinoma, Renal Cell 1Carcinoma 1Anus Neoplasms 1Advanced Refractory Solid Tumors 1Advanced Malignant Solid Tumor 1

Interventions

Cisplatin 44Paclitaxel 21Radiotherapy 20Brachytherapy 19Carboplatin 18Bevacizumab 7Drug Therapy 6camrelizumab 5toripalimab 4nimotuzumab 4Radiation 4Neoadjuvant Therapy 4Gemcitabine 4tislelizumab 3sintilimab 3pembrolizumab 3apatinib 3Vaccines 3TP protocol 3Surgical Procedures, Operative 3Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 3nedaplatin 2fludarabine 2endostar protein 2anlotinib 2Topotecan 2Surveys and Questionnaires 2Sentinel Lymph Node Biopsy 2Radiotherapy, Intensity-Modulated 2Mindfulness 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Uterine Cervical Neoplasms × Interleukin-2 × Clear all
NCT05895370 2023-06-08

GI-HPVT-01

BGI, China

Phase 1 Unknown
12 enrolled
Gynecologic

Uterine Cervical Neoplasms, Recurrence

NCT05122221 2022-06-28

CRTE7A2-01 TCR-T Cell for HPV-16 Positive Advanced Cervical, Anal, or Head and Neck Cancers

Corregene Biotechnology Co., Ltd

Phase 1 Unknown
12 enrolled
GastrointestinalGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡